Hypertonic Saline vs. Mannitol for Elevated Intercranial Pressure
Stopped early · Phase 3
Conditions studied: Traumatic Brain Injury, Elevated Intracranial Pressure
In brief
This study examines the role of osmotic agents in controlling brain swelling in brain injured individuals. Two osmotic agents -- mannitol and hypertonic saline -- are in common use, and they will be compared in the context of a randomized clinical trial. The goal is to determine if these agent differ in their ability to control episodes of brain swelling.
Key facts
- Study ID
- NCT01111682
- Run by
- University of Cincinnati
- People needed
- 5
- Starts
- 2010-04-01
- Expected to finish
- 2010-11-01
- Last updated by the study team
- 2013-03-05
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- closed traumatic brain injury
- either (i) GCS score 3-8 (inclusive), or (ii) GCS motor score of 5 or less AND abnormal admission CT scan showing intracranial pathology
- hemodynamically stable with systolic blood pressure greater than 90 mmHg
- at least 1 reactive pupil
- age between 18y and 70y (inclusive)
- INR less than 1.5
You may not qualify if…
- actively on hypertonic saline or mannitol
- hypernatremia (>145 meq/L)
- anuric or with creatinine greater than or equal to 2.5
- known seizure disorder
- penetrating head trauma
- suspected anoxic events
- history of, or CT confirmation of, previous brain injury
- any injury that, in the opinion of the Principal Investigator, has a high likelihood of death with the first 72 hours post-injury
- any treatment, condition, or injury that contraindicates treatment with hypertonic saline
Where it is running
- University Hospital — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.